According to a recent LinkedIn post from Peer AI, the company is emphasizing a new metric called Post-Edit Distance for evaluating AI-generated regulatory documents. The metric tracks the percentage of text changed between an AI’s initial draft and the final approved version, offering teams a quantitative way to assess and benchmark quality over time.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The post highlights that this approach aims to give compliance and regulatory users a baseline to determine whether AI outputs are becoming closer to “approval-ready” drafts. It also points to a peer-reviewed article by Peer AI’s Head of Engineering in ACRP’s Clinical Researcher, suggesting the firm is seeking validation and visibility within the clinical research and regulatory community.
For investors, the focus on measurable quality in AI-generated documents may signal Peer AI’s attempt to differentiate its products in a highly scrutinized regulatory workflow niche. If adopted by customers, a standardized metric could increase user trust, support more data-driven ROI discussions, and potentially improve product stickiness in regulated industries.
The association with a recognized professional body like ACRP could enhance Peer AI’s credibility among life sciences and clinical research clients. Over time, stronger positioning in this segment may translate into deeper enterprise penetration, higher recurring revenue potential, and a more defensible competitive moat in AI-enabled regulatory documentation.